Making AIDS treatment affordable for all sufferers
Tags: AIDS (Disease) -- Treatment; HIV (Viruses)
Related Articles
- Aids Drug Available In United Kingdom. Helquist, Michael // Advocate;1/19/88, Issue 490, p9
Reports on the availability in Great Britain AL-721, a drug for treating AIDS. Physicians' basis for prescribing the drug; Status in the United States; Start of the U.S. National Institutes of Health's study of its effectiveness against persistent generalized lymphadenopathy.
- More Drug Reports. Helquist, Michael // Advocate;3/18/86, Issue 442, p25
Reports that researchers at the AIDS branch of the U.S. Centers for Disease Control continue to conduct tests of potentially therapeutic agents to be used against AIDS. Ability of rifabutin to block the in vitro infectivity and replication of the AIDS virus; Ability of rifabutin to penetrate...
- Living With AIDS--20 YEARS LATER. Bullers, Anne Christiansen // FDA Consumer;Nov/Dec2001, Vol. 35 Issue 6, p29
Examines several drugs for treating AIDS and the efforts being done to improve the lives of people with AIDS. Process of the spread of HIV; Drug issues being discussed within the medical community and outside of it; Reason for waiting the immune system to weaken significantly before taking drugs.
- Living With The Enemy: Never Letting Our Guard Down. Murray, Jeffrey S. // FDA Consumer;Nov/Dec2001, Vol. 35 Issue 6, p40
Comments on the treatment of HIV and AIDS. Difference of the treatment of HIV with other chronic illnesses; First step in dealing with HIV battle fatigue; Characteristics of drugs that are in urgent search for treating HIV.
- Baseline Human Immunodeficiency Virus Type 1 Phenotype, Genotype, and RNA Response after... Para, Michael F.; Glidden, David V.; Coombs, Robert W.; Collier, Ann C.; Condra, Jon H.; Craig, Charles; Bassett, Roland; Leavitt, Randi; Snyder, Sally; McAulliffe, Vincent; Boucher, Charles // Journal of Infectious Diseases;9/1/2000, Vol. 182 Issue 3, p733
Investigates the phenotype, genotype and RNA response of baseline HIV type 1 after switching from long-term hard-capsule saquinavir (SQV) to indinavir or soft-gel-capsule saquinavir in AIDS clinical trials group protocol 333. Correlation of the number of substitutions with baseline CD4 cell...
- AIDS DRUGS WORK. Austin, Sara // Marie Claire (US);Dec2002, Vol. 9 Issue 12, p110
Reports on the high costs of drugs for AIDS in developing countries as of December 2002. Statistics on Africans with AIDS or HIV; Comments of Yinka Jegede, an HIV-positive Nigerian, on affordability of drugs for AIDS by middle-class Nigerians; Decline in the costs of AIDS drugs from 1997 to...
- CNE/CME questions. // AIDS Alert;Feb2009, Vol. 24 Issue 2, p23
A quiz concerning the treatment for HIV and AIDS is presented.
- CNE/CME QUESTIONS. // AIDS Alert;May2010, Vol. 25 Issue 5, p59
A quiz is presented related to medical care for human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) patients.
- Oral Dextran Sulfate (UA001) in the Treatment of the Acquired Immunodeficiency Syndrome (AIDS) and AIDS-Related Complex. Abrams, Donald I.; Kuno, Suchiko; Wong, Roberta; Jeffords, Kevan; Nash, Marti; Mologhan, J.B.; Gorter, Robert; Ueno, Ryuji // Annals of Internal Medicine;2/1/89, Vol. 110 Issue 3, p183
Presents a study that evaluated the tolerance and safety of oral dextran sulfate, a potent in-vitro inhibitor of human immunodeficiency virus (HIV) in patients with AIDS and related complications. Methodology used in the study; Profile of patients; Interventions; Diagnosis; Discussion on the...
